Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Mauro

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2021
Lifelong TKI therapy: how to manage cardiovascular and other risksMichael J Mauro
Current Treatment Options in Oncology|December 25, 2007
Mutational analysis and overcoming imatinib resistance in chronic myeloid leukemia with novel tyrosine kinase inhibitorsMichael J Mauro
The New England Journal of Medicine|August 22, 2003
Images in clinical medicine. Hyperleukocytosis in acute myeloid leukemiaMichael J Mauro
Therapeutic Advances in Hematology|April 5, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|April 23, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|June 5, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|April 24, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|April 26, 2013
EditorialMichael J Mauro
Current Opinion in Hematology|January 5, 2019
Novel tyrosine kinase inhibitors for patients with inadequate response in chronic myeloid leukemiaMichael J Mauro
Best Practice & Research. Clinical Haematology|November 15, 2016
Chronic myeloid leukemia: Is it dusk or dawn?Michael J Mauro
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Hematology. American Society of Hematology. Education Program|December 10, 2021
Lifelong TKI therapy: how to manage cardiovascular and other risksMichael J Mauro
Current Treatment Options in Oncology|December 25, 2007
Mutational analysis and overcoming imatinib resistance in chronic myeloid leukemia with novel tyrosine kinase inhibitorsMichael J Mauro
The New England Journal of Medicine|August 22, 2003
Images in clinical medicine. Hyperleukocytosis in acute myeloid leukemiaMichael J Mauro
Therapeutic Advances in Hematology|April 5, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|April 23, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|June 5, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|April 24, 2013
EditorialMichael J Mauro
Therapeutic Advances in Hematology|April 26, 2013
EditorialMichael J Mauro
Current Opinion in Hematology|January 5, 2019
Novel tyrosine kinase inhibitors for patients with inadequate response in chronic myeloid leukemiaMichael J Mauro
Best Practice & Research. Clinical Haematology|November 15, 2016
Chronic myeloid leukemia: Is it dusk or dawn?Michael J Mauro
Pageof 13